Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prostate Cancer
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Leukemia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Trial Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Clinical Trial Market Perspective (2018-2033)
2.2 Oncology Clinical Trial Growth Trends by Region
2.2.1 Global Oncology Clinical Trial Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oncology Clinical Trial Historic Market Size by Region (2018-2023)
2.2.3 Oncology Clinical Trial Forecasted Market Size by Region (2024-2033)
2.3 Oncology Clinical Trial Market Dynamics
2.3.1 Oncology Clinical Trial Industry Trends
2.3.2 Oncology Clinical Trial Market Drivers
2.3.3 Oncology Clinical Trial Market Challenges
2.3.4 Oncology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Trial Players by Revenue
3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2018-2023)
3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
3.4 Global Oncology Clinical Trial Market Concentration Ratio
3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2022
3.5 Oncology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Oncology Clinical Trial Product Solution and Service
3.7 Date of Enter into Oncology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Clinical Trial Breakdown Data by Type
4.1 Global Oncology Clinical Trial Historic Market Size by Type (2018-2023)
4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2024-2033)
5 Oncology Clinical Trial Breakdown Data by Application
5.1 Global Oncology Clinical Trial Historic Market Size by Application (2018-2023)
5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oncology Clinical Trial Market Size (2018-2033)
6.2 North America Oncology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oncology Clinical Trial Market Size by Country (2018-2023)
6.4 North America Oncology Clinical Trial Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Clinical Trial Market Size (2018-2033)
7.2 Europe Oncology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oncology Clinical Trial Market Size by Country (2018-2023)
7.4 Europe Oncology Clinical Trial Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Trial Market Size (2018-2033)
8.2 Asia-Pacific Oncology Clinical Trial Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Clinical Trial Market Size (2018-2033)
9.2 Latin America Oncology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oncology Clinical Trial Market Size by Country (2018-2023)
9.4 Latin America Oncology Clinical Trial Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Trial Market Size (2018-2033)
10.2 Middle East & Africa Oncology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Oncology Clinical Trial Introduction
11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2018-2023)
11.1.5 IQVIA Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Detail
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2018-2023)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc
11.3.1 ICON Plc Company Detail
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Oncology Clinical Trial Introduction
11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2018-2023)
11.3.5 ICON Plc Recent Development
11.4 Medelis, Inc.
11.4.1 Medelis, Inc. Company Detail
11.4.2 Medelis, Inc. Business Overview
11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2018-2023)
11.4.5 Medelis, Inc. Recent Development
11.5 Medpace Holdings, Inc.
11.5.1 Medpace Holdings, Inc. Company Detail
11.5.2 Medpace Holdings, Inc. Business Overview
11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2018-2023)
11.5.5 Medpace Holdings, Inc. Recent Development
11.6 PAREXEL International
11.6.1 PAREXEL International Company Detail
11.6.2 PAREXEL International Business Overview
11.6.3 PAREXEL International Oncology Clinical Trial Introduction
11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2018-2023)
11.6.5 PAREXEL International Recent Development
11.7 Pharmaceutical Product Development, LLC
11.7.1 Pharmaceutical Product Development, LLC Company Detail
11.7.2 Pharmaceutical Product Development, LLC Business Overview
11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2018-2023)
11.7.5 Pharmaceutical Product Development, LLC Recent Development
11.8 Pivotal
11.8.1 Pivotal Company Detail
11.8.2 Pivotal Business Overview
11.8.3 Pivotal Oncology Clinical Trial Introduction
11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2018-2023)
11.8.5 Pivotal Recent Development
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Detail
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2018-2023)
11.9.5 PRA Health Sciences Recent Development
11.10 Syneos Health
11.10.1 Syneos Health Company Detail
11.10.2 Syneos Health Business Overview
11.10.3 Syneos Health Oncology Clinical Trial Introduction
11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2018-2023)
11.10.5 Syneos Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncology Clinical Trial Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prostate Cancer
Table 3. Key Players of Lung Cancer
Table 4. Key Players of Breast Cancer
Table 5. Key Players of Leukemia
Table 6. Key Players of Others
Table 7. Global Oncology Clinical Trial Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Oncology Clinical Trial Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Oncology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Oncology Clinical Trial Market Share by Region (2018-2023)
Table 11. Global Oncology Clinical Trial Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Oncology Clinical Trial Market Share by Region (2024-2033)
Table 13. Oncology Clinical Trial Market Trends
Table 14. Oncology Clinical Trial Market Drivers
Table 15. Oncology Clinical Trial Market Challenges
Table 16. Oncology Clinical Trial Market Restraints
Table 17. Global Oncology Clinical Trial Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Oncology Clinical Trial Market Share by Players (2018-2023)
Table 19. Global Top Oncology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Clinical Trial as of 2022)
Table 20. Ranking of Global Top Oncology Clinical Trial Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Oncology Clinical Trial Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Clinical Trial Product Solution and Service
Table 24. Date of Enter into Oncology Clinical Trial Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Oncology Clinical Trial Revenue Market Share by Type (2018-2023)
Table 28. Global Oncology Clinical Trial Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Oncology Clinical Trial Revenue Market Share by Type (2024-2033)
Table 30. Global Oncology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Oncology Clinical Trial Revenue Market Share by Application (2018-2023)
Table 32. Global Oncology Clinical Trial Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Oncology Clinical Trial Revenue Market Share by Application (2024-2033)
Table 34. North America Oncology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Oncology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Oncology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Oncology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Oncology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Oncology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Oncology Clinical Trial Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Oncology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Oncology Clinical Trial Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Oncology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Oncology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Oncology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Oncology Clinical Trial Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Oncology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Oncology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 49. IQVIA Company Detail
Table 50. IQVIA Business Overview
Table 51. IQVIA Oncology Clinical Trial Product
Table 52. IQVIA Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 53. IQVIA Recent Development
Table 54. Charles River Laboratory Company Detail
Table 55. Charles River Laboratory Business Overview
Table 56. Charles River Laboratory Oncology Clinical Trial Product
Table 57. Charles River Laboratory Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 58. Charles River Laboratory Recent Development
Table 59. ICON Plc Company Detail
Table 60. ICON Plc Business Overview
Table 61. ICON Plc Oncology Clinical Trial Product
Table 62. ICON Plc Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 63. ICON Plc Recent Development
Table 64. Medelis, Inc. Company Detail
Table 65. Medelis, Inc. Business Overview
Table 66. Medelis, Inc. Oncology Clinical Trial Product
Table 67. Medelis, Inc. Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 68. Medelis, Inc. Recent Development
Table 69. Medpace Holdings, Inc. Company Detail
Table 70. Medpace Holdings, Inc. Business Overview
Table 71. Medpace Holdings, Inc. Oncology Clinical Trial Product
Table 72. Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 73. Medpace Holdings, Inc. Recent Development
Table 74. PAREXEL International Company Detail
Table 75. PAREXEL International Business Overview
Table 76. PAREXEL International Oncology Clinical Trial Product
Table 77. PAREXEL International Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 78. PAREXEL International Recent Development
Table 79. Pharmaceutical Product Development, LLC Company Detail
Table 80. Pharmaceutical Product Development, LLC Business Overview
Table 81. Pharmaceutical Product Development, LLC Oncology Clinical Trial Product
Table 82. Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 83. Pharmaceutical Product Development, LLC Recent Development
Table 84. Pivotal Company Detail
Table 85. Pivotal Business Overview
Table 86. Pivotal Oncology Clinical Trial Product
Table 87. Pivotal Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 88. Pivotal Recent Development
Table 89. PRA Health Sciences Company Detail
Table 90. PRA Health Sciences Business Overview
Table 91. PRA Health Sciences Oncology Clinical Trial Product
Table 92. PRA Health Sciences Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 93. PRA Health Sciences Recent Development
Table 94. Syneos Health Company Detail
Table 95. Syneos Health Business Overview
Table 96. Syneos Health Oncology Clinical Trial Product
Table 97. Syneos Health Revenue in Oncology Clinical Trial Business (2018-2023) & (US$ Million)
Table 98. Syneos Health Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Clinical Trial Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oncology Clinical Trial Market Share by Type: 2022 VS 2033
Figure 3. Prostate Cancer Features
Figure 4. Lung Cancer Features
Figure 5. Breast Cancer Features
Figure 6. Leukemia Features
Figure 7. Others Features
Figure 8. Global Oncology Clinical Trial Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Oncology Clinical Trial Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Lab Case Studies
Figure 13. Oncology Clinical Trial Report Years Considered
Figure 14. Global Oncology Clinical Trial Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Oncology Clinical Trial Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Oncology Clinical Trial Market Share by Region: 2022 VS 2033
Figure 17. Global Oncology Clinical Trial Market Share by Players in 2022
Figure 18. Global Top Oncology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Clinical Trial as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Oncology Clinical Trial Revenue in 2022
Figure 20. North America Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Oncology Clinical Trial Market Share by Country (2018-2033)
Figure 22. United States Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Oncology Clinical Trial Market Share by Country (2018-2033)
Figure 26. Germany Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Oncology Clinical Trial Market Share by Region (2018-2033)
Figure 34. China Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Oncology Clinical Trial Market Share by Country (2018-2033)
Figure 42. Mexico Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Oncology Clinical Trial Market Share by Country (2018-2033)
Figure 46. Turkey Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Oncology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. IQVIA Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 49. Charles River Laboratory Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 50. ICON Plc Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 51. Medelis, Inc. Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 52. Medpace Holdings, Inc. Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 53. PAREXEL International Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 54. Pharmaceutical Product Development, LLC Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 55. Pivotal Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 56. PRA Health Sciences Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 57. Syneos Health Revenue Growth Rate in Oncology Clinical Trial Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed